Information Provided By: 
Fly News Breaks for May 25, 2016
DEPO
May 25, 2016 | 07:56 EDT
Janney Capital analyst Ken Trbovich noted that Depomed last increased prices in Dec. 2015 and forecast that the company, which has already gone beyond its typical 5-6 month interval for hikes, is set to up prices again sometime between August and October. The analyst, who expects price increases to increase confidence in the company's revenue forecasts and more than offset recent weakness in prescription trends for Gralise and Lazanda, keeps a Buy rating on Depomed with a $28 fair value estimate.
News For DEPO From the Last 2 Days
There are no results for your query DEPO
